ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Introducing AAMI neXus, the Evolved International Standards Conference

Arlington, Virginia, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The Association for the Advancement of Medical Instrumentation (AAMI) is pleased to announce that it will host AAMI neXus: The Medical Device Standards Conference, the medical device sector’s leading event covering health technology standards and regulatory requirements.

Held from February 20 to 23, 2024, at the Omni Shoreham Hotel in Washington, D.C., AAMI neXus takes the place of the International Standards Conference (ISC). Since 1991, ISC was the must attend conference for industry and regulatory leaders involved in the development and adoption of medical device standards. AAMI neXus features ISC’s previous programming but includes a new focus on applying medical device standards.

Robert Burroughs, AAMI chief learning and development officer said, “We’re excited to bring the same focus from ISC to AAMI neXus but to add material on standards application. AAMI neXus will address the development, adoption, and application of industry standards.”

New sessions and trainings will tackle how industry professionals can develop, adopt, and apply standards and regulations. This will include deep-dive symposia on new regulatory changes and developments and ‘101-level’ bootcamps for those new to the industry or a particular technical area.

Jeffrey Shuren, Director of the Center for Devices and Radiological Health (CDRH) at FDA, will deliver a keynote on February 20, the first day of AAMI neXus. The complete program of sessions, events, and workshops will be released in November. Issue areas addressed at AAMI neXus will include:

  • FDA developments related to Accredition Scheme for Conformity Assessment (ASCA) and electronic Submission Template and Resources (eSTAR).
  • FDA’s switch to ISO 13485 and implications for the medical device industry.
  • Updates on the FDA case for quality and the Voluntary Improvement Program.
  • Global markets and regulations in the European Union, Asia, Latin America, Africa, and elsewhere.
  • Industrial sterilization, biocompatibility, and combination products.
  • New and emerging issues like cloud computing, AI, and cybersecurity threats.
  • Upcoming revisions to the IEC 601601 series for electromedical devices.
  • Technical challenges to sustainability and health equity.
  • And much more!

Registration for AAMI members and member groups can be found here. Registration is also open for non-members, who are also strongly encouraged to attend. AAMI’s events team can be reached at events@aami.org in the event of questions about registration, programming, or group registration rates.




Dan Visnovsky
Media Relations Manager
Association for the Advancement of Medical Instrumentation
dvisnovsky@aami.org

Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.